Foster & Motley Inc. Has $10.77 Million Stock Holdings in Aflac Incorporated (NYSE:AFL)

Foster & Motley Inc. lowered its holdings in shares of Aflac Incorporated (NYSE:AFL - Free Report) by 3.2% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 96,900 shares of the financial services provider's stock after selling 3,221 shares during the period. Foster & Motley Inc.'s holdings in Aflac were worth $10,774,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Golden State Wealth Management LLC increased its position in Aflac by 121.9% during the first quarter. Golden State Wealth Management LLC now owns 304 shares of the financial services provider's stock worth $34,000 after purchasing an additional 167 shares during the last quarter. Garde Capital Inc. acquired a new position in Aflac during the first quarter worth approximately $36,000. Meeder Asset Management Inc. increased its position in Aflac by 90.8% during the first quarter. Meeder Asset Management Inc. now owns 330 shares of the financial services provider's stock worth $37,000 after purchasing an additional 157 shares during the last quarter. Capital A Wealth Management LLC acquired a new position in Aflac during the fourth quarter worth approximately $38,000. Finally, NBC Securities Inc. acquired a new position in Aflac during the first quarter worth approximately $44,000. Institutional investors and hedge funds own 67.44% of the company's stock.

Insider Activity

In other news, Director Masatoshi Koide sold 37,000 shares of Aflac stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $105.59, for a total value of $3,906,830.00. Following the transaction, the director owned 70,992 shares of the company's stock, valued at $7,496,045.28. This trade represents a 34.26% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Arthur Reginald Collins sold 2,750 shares of Aflac stock in a transaction that occurred on Thursday, May 15th. The shares were sold at an average price of $105.70, for a total transaction of $290,675.00. Following the completion of the transaction, the director directly owned 6,728 shares in the company, valued at approximately $711,149.60. This represents a 29.01% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 40,750 shares of company stock valued at $4,304,295 over the last 90 days. 0.90% of the stock is currently owned by company insiders.

Aflac Stock Down 1.3%

Shares of NYSE AFL traded down $1.26 during mid-day trading on Friday, reaching $98.10. The company had a trading volume of 2,768,313 shares, compared to its average volume of 2,134,279. The stock has a fifty day moving average of $102.67 and a two-hundred day moving average of $105.09. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.09 and a current ratio of 0.09. The company has a market capitalization of $53.04 billion, a price-to-earnings ratio of 15.33, a PEG ratio of 3.05 and a beta of 0.81. Aflac Incorporated has a 12-month low of $95.97 and a 12-month high of $115.50.

Aflac (NYSE:AFL - Get Free Report) last issued its quarterly earnings data on Wednesday, April 30th. The financial services provider reported $1.66 earnings per share for the quarter, missing the consensus estimate of $1.67 by ($0.01). The business had revenue of $3.40 billion for the quarter, compared to the consensus estimate of $4.53 billion. Aflac had a net margin of 21.27% and a return on equity of 15.55%. Aflac's revenue was down 37.5% compared to the same quarter last year. During the same period in the previous year, the business posted $1.66 EPS. As a group, equities research analysts expect that Aflac Incorporated will post 6.88 EPS for the current year.

Analyst Upgrades and Downgrades

AFL has been the subject of several analyst reports. Wall Street Zen downgraded shares of Aflac from a "hold" rating to a "sell" rating in a research note on Monday, May 5th. JPMorgan Chase & Co. upped their target price on shares of Aflac from $96.00 to $100.00 and gave the company a "neutral" rating in a research note on Tuesday, July 8th. Morgan Stanley upped their target price on shares of Aflac from $100.00 to $105.00 and gave the company an "equal weight" rating in a research note on Monday, May 19th. Wells Fargo & Company upped their target price on shares of Aflac from $103.00 to $105.00 and gave the company an "equal weight" rating in a research note on Thursday, July 10th. Finally, Raymond James Financial cut their price target on shares of Aflac from $115.00 to $110.00 and set an "outperform" rating on the stock in a report on Thursday, May 29th. Three equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $108.15.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.